跳至主要内容
临床试验/CTRI/2022/07/043789
CTRI/2022/07/043789已完成4 期

A post market clinical follow up prospective study to evaluate safety and performance of Eye Preparations (Hypromellose 0.3% w/v Sodium Hyaluronate 0.1% w/v Eye Drops).

STERICON PHARMA PRIVATE LIMITED0 个研究点目标入组 54 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Subjects who experience dryness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment
  • -Subjects wearing contact lenses who experience dryness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment

排除标准

  • -Subjects who are not willing to participate in the study
  • -Anyone with known allergic reaction to Hypromellose +Sodium Hyaluronate eye drops
  • -Subjects with existing eye infection
  • -Subjects undergone recent (6 weeks) cataract surgery who are on other eye medication

研究者

相似试验

The purpose of the study is to evaluate safety and... | 临床试验